Daelight Solutions Names Sumit Honwad as Director of Technology

Daelight Solutions, an IT consulting company focused on meeting the information challenges of life sciences companies, recently welcomed Sumit Honwad as Director of Technology to support the company’s expanding client base.

In alignment with the company’s commitment to meeting the increasing need for technological support in the life sciences industry, Honwad brings to his new position an in-depth understanding of validation requirements in the pharmaceutical industry specific to technology application implementations and ongoing application management.

“Our growing roster of clients reflects the industry’s increasing need for technological support at all levels, and Sumit is a welcome addition to our team,” said Dan Wheeler, founder and CEO of Daelight Solutions. “Sumit’s strong background in designing, developing and implementing technology solutions enhance our company’s ability to meet the evolving demands of the life sciences industry.”

Prior to joining Daelight, Honwad worked for Grifols as Technical Application Manager and Senior Business Analyst, where he successfully led a project to design and develop a new laboratory information management system application in accordance with Agile/GAMP methodology. He received his master’s degree in business administration, general management, from North Carolina State University.

About Daelight Solutions

Daelight Solutions is an IT consulting company that is relentlessly focused on meeting the enterprise information challenges of the life sciences industry. Centered on delivering meaningful outcomes and value for clients, Daelight has an expert team of life sciences IT specialists with decades of experience in the space. Daelight provides clients in the pharmaceutical, biotech and medical device industries with services that ensure IT projects begin with the real world in mind. Daelight Solutions is based in Princeton, NJ. Learn more at www.daelightsolutions.com or follow us on LinkedIn and Twitter.

SHARE THIS POST